5% stakes
Invus Global Management
Institution
- 5% stake reports
- 31
- 5% stake stocks
- 19
- Latest report
- 26/09/17
5% stake reports
| Stock | ||
|---|---|---|
| Yarrow Bioscience YARW09/17 | 7.2%675,000 sh | First report |
| enGene Therapeutics ENGN08/13 | 9.3%6,256,662 sh | +1.5pp |
| Scholar Rock Holding SRRK08/13 | 8%9,575,013 sh | −3.4pp |
| Abivax ABVX08/13 | 6%4,825,759 sh | +1.0pp |
| Hemab Therapeutics Holdings COAG08/07 | 5.1%2,366,235 sh | First report |
| Agenus AGEN07/17 | 9.99%4,533,755 sh | First report |
| Eloxx Pharmaceuticals ELOX06/15 | 9.99%403,586 sh | First report |
| Lexicon Pharmaceuticals LXRX05/08 | 39.4%175,156,062 sh | +3.2pp |
| enGene Therapeutics ENGN05/05 | 7.8%5,253,159 sh | +1.5pp |
| Tenax Therapeutics TENX05/04 | 2.5%427,141 sh | −6.9pp |
| Tango Therapeutics TNGX05/04 | 4%5,657,105 sh | −2.1pp |
| Neumora Therapeutics NMRA05/04 | 4.7%8,497,822 sh | −0.7pp |
| Bicycle Therapeutics BCYC05/04 | 3.1%1,560,882 sh | −3.2pp |
| Olema Pharmaceuticals OLMA03/20 | 5.1%4,461,949 sh | First report |
| Bicycle Therapeutics BCYC03/03 | 6.3%3,149,049 sh | First report |
| Neumora Therapeutics NMRA02/19 | 5.4%8,997,822 sh | First report |
| Rezolute RZLT02/13 | 0%0 sh | −5.4pp |
| DBV Technologies DBVT02/13 | 6.2%14,350,960 sh | −1.6pp |
| Abivax ABVX02/13 | 5%3,922,995 sh | −3.5pp |
| Lexicon Pharmaceuticals LXRX02/02 | 36.2%154,734,327 sh | No earlier report |
